Genesys Capital participates in US$40 Million Series E financing of Invitae
Invitae Corp, a genetic diagnostics company based in San Francisco, Calif., has secured a US$40 million Series E financing. Investors in the round included Canadian venture capital firm Genesys Capital, as well as Genomic Health Inc, GHDX -5.77% , Randy Scott, Thomas McNerney & Partners, Redmile Group and Casdin Capital. Invitae will use the new funding to accelerate the development of its genetic tests for hereditary disorders, and to expand into international markets. Based in Toronto, Genesys Capital is focused on investing in and building companies in high-growth sectors of healthcare and biotechnology.
11 December 2013•2 mins read
